Mineralys Therapeutics, Inc.
MLYS · NASDAQ · USD
$23.37
+0.99 4.42%todayNot financial advice.
- Open
- 22.49
- Day range
- 22.37 - 23.68
- 52-week range
- 21.46 - 47.65
- Volume
- 895.31K
- Market cap
- 2.07B
- P/E ratio
- —
- EPS
- -4.24
- Dividend yield
- 0.00%
- Beta
- 1.67
Performance
W
−2.67%
1M
−24.30%
3M
−19.02%
6M
−14.21%
YTD
−35.51%
Y
−37.98%
5Y
+10.76%
All
+10.76%
In the news
Oct 9
Mineralys Therapeutics Reports Positive Blood Pressure Trial Data for Lorundrostat
Mineralys Therapeutics reported positive clinical data for its blood pressure drug lorundrostat, demonstrating significant reductions in hypertension.
Company news
Oct 9
Mineralys Therapeutics Reports Positive Clinical Trial Data for Hypertension Treatment Lorundrostat
Mineralys Therapeutics released encouraging data from trials evaluating its hypertension treatment candidate lorundrostat.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-MLYS" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Mineralys Therapeutics, Inc. (MLYS) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-MLYS">MLYS stock price</a> by FreeTheAI Stocks</p>